Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Moderna Gets Good News, but Another Biotech Stock Is Falling Again

Source: 
Motley Fool
snippet: 
  • The Nasdaq kept leading markets higher.
  • Moderna stock rose after the company announced favorable trial results for its candidate RSV vaccine.
  • Bluebird Bio fell on news of a secondary stock offering.